ESG in Life Sciences Summit East on October 28-30, 2025 in Boston, United States

In 2025, ESG professionals in life sciences face more complexity and more pressure than ever before. Political headwinds in the U.S., reporting rollbacks in Europe, and increasing scrutiny from stakeholders have made ESG initiatives an increasingly polarized area of the business. However, amid shifting priorities and blurred regulatory boundaries, one thing remains constant: the undeniable value of ESG as a driver of innovation, resilience, and positive impact across business, people, patients, and the planet.

At a time when resources are tighter, internal alignment is harder to secure, and Scope 3 emissions and decarbonization remain persistent challenges, the 4th ESG in Life Sciences Summit East returns as the industry’s most trusted and practical forum for sustainability leaders in pharma, biotech, medtech, and life sciences services.

Whether you're working to build internal buy-in, align sustainability with commercial goals, strengthen supplier collaboration, or navigate emerging reporting expectations, this summit is designed to meet you where you are - and help you move forward.

Built with expert insights from both industry giants and SMEs, the 2025 agenda will tackle your most pressing challenges head-on. From reporting strategy and stakeholder engagement to supply chain optimization and climate risk management, you’ll leave with the insights and tools you need to keep ESG a central pillar of long-term success - even in the face of uncertainty.

URLs:

Tickets: https://go.evvnt.com/3136174-2?pid=10008

Brochure: https://go.evvnt.com/3136174-3?pid=10008

Time: 8:00 AM - 5:15 PM

Prices:

Conference + Workshop Day (3 Day Pass) - Life Sciences Organization Pricing: USD 3197.00,

Conference Only (2 Day Pass) - Life Sciences Organization Pricing: USD 2399.00,

Conference + Workshop Day (3 Day Pass) - Solution Provider Pricing: USD 4397.00,

Conference Only (2 Day Pass) - Solution Provider Pricing: USD 3199.00

Speakers: Amy Cannon, Executive Director and Co-Founder, Beyond Benign Foundation, Areej Nitowski, Green Chemistry Education , Life Science, Sustainability and Social Business Innovation Manager, MilliporeSigma, Briana Marvuglio, Executive Director - Environment and Sustainability Enablement, BMS, Derek Noah, Director - Sustainability, Teleflex, Erin Woodward, Director - Global Sustainability, Bio-Techne Corporation, Frances Levy, Environmental, Social, Governance and Regulatory Compliance Specialist, Integra LifeSciences, Hollie Grant, Director, Global Sustainability, Takeda Pharmaceutical, Holly Ferreira, Senior Director - Environmental, Social and Governance Controller, Thermo Fisher Scientific Inc, Jeremy Hertel, Director - Global Compliance, ESG and Logistics, STgenetics, John Hodges, Director of Sustainability Strategy and Reporting, BMS, Julia Koehler, Director Corporate Strategy and Global Lead Employee Sustainability Group, Biogen, Koen Postuma, Director, Procurement - Scope 3 Program Manager, Merck, Lindsey Greenberger, Director, Corporate Responsibility, Quest Diagnostics, Matthew Yamatin, Director - Sustainability Program, Thermo Fisher Scientific, Rizwana Seeham, Director - Equity, Diversity, and Inclusion, Blueprint Medicines, Robert Ellsworth, Global Director - Enterprise Sustainability and Operationalizing Our Sustainability Principles, Medtronic, Samantha Smith, Engineering Director - Product Stewardship, Former, Sandra Costa Agusti, Senior Manager - Sustainability, Grifols, Sandra Yi-Fuller, Head of Corporate Responsibility and Reporting, Biogen, Sara Boutin, Sustainability Program, Procurement and Excellence Manager, Dentsply International Professional Division, Sarah Stiff, ESG Controller, Legend Biotech, Vinayak Gorur, Senior Director - Sustainability and ESG, Sonic Healthcare, Zachary Rouhas, Global Head of Environmental, Social and Governance, Integra LifeSciences